Atlas Trials

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

Clinical trial NCT03442504 · UNKNOWN

Trial details

NCT number
NCT03442504
Sponsor
Institut Cancerologie de l'Ouest
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2017-03-15
Primary completion
2023-01-11
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.